Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Scilex Holding Company

SCLXWNASDAQ
Healthcare
Drug Manufacturers - General
$0.15
$-0.01(-7.18%)
U.S. Market opens in 15h 29m

Scilex Holding Company (SCLXW) Stock Overview

Explore Scilex Holding Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.3M
P/E Ratio-0.25
EPS (TTM)N/A
ROE1.81%
Fundamental Analysis

AI Price Forecasts

1 Month$0.09
3 Months$0.05
1 Year Target$0.00

SCLXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scilex Holding Company (SCLXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.25 and a market capitalization of 1.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.20%
5-Day Change
25.52%
1-Month Change
23.64%
3-Month Change
-1.63%
6-Month Change
-69.74%
Year-to-Date (YTD) Change
42.83%
1-Year Change
117.10%
3-Year Change
-88.43%
5-Year Change
-72.96%
All-Time (Max) Change
-72.96%

Contact Information

650 516 4310
960 San Antonio Road, Palo Alto, CA, 94303

Company Facts

1,150 Employees
IPO DateMar 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions